Kester Capital-backed Evestia Clinical to merge with Atlantic Research Group.

Kester Capital-backed Evestia Clinical, a global CRO company providing clinical development services, agreed to merge with Atlantic Research Group, a contract research organization for clinical trial services. Financial terms were not disclosed. "We’re incredibly excited to be joining forces with ARG as we accelerate our journey to build Evestia Clinical into a leading mid-tier specialist CRO with a truly global reach. The combined Group will immediately provide benefits for our clients, and I look forward to working with Paul, Lyle and the broader ARG team as we grow Evestia Clinical together and deliver the highest quality services to clients worldwide," Lewis Cameron, Evestia Clinical CEO.